Back to search results

LEGACY CARE: Legal Support for Colorectal Cancer Caregivers

This study, called LEGACY CARE, is looking at how free legal services can help caregivers and patients dealing with advanced colorectal cancer. You and your caregiver would receive personalized legal care from Cancer Legal Care (CLC), a nonprofit organization in the Twin Cities of Minnesota. The study wants to see if these services are practical, acceptable, and helpful for improving financial and emotional well-being. To join, the patient must have advanced colorectal cancer (Stage III or IV) diagnosed within the last 3 months, be starting or planning to start cancer treatment, and have a life expectancy of over 6 months. The study is currently unclear on its recruitment status.

Study design
This is a single-center, single-arm pilot study involving about 20 participants (patient-caregiver pairs). It's designed to test the feasibility and initial effectiveness of the intervention.
What's involved
Participants will receive free, personalized legal care services for a duration of 3 months. They may continue to access these services beyond this period.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint for measuring feasibility is at 3 months, which suggests the main study period is 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07153016

LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer

Recruiting
NAAges 18+InterventionalSupportive care
Masonic Cancer Center, University of Minnesota
~20 participants
Updated 2025-09-16 on ClinicalTrials.gov
What's tested:Legal Services

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility
Measured over 3 months

Conditions

Caregiver Burden
Colorectal Cancer
Legal Intervention

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
Minnesota1

Who to contact

Arjun Gupta, MBBS
[email protected]
612-626-5906
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of advanced stage (Stage III or Stage IV) colorectal cancer within the past 3 months.
Initiated or planning to initiate systemic cancer therapy.
Able to identify a caregiver for study participation.
Estimated life expectancy of over 6 months in the opinion of the treating oncologist.
18 years of age or older at the time of consent.
Able to understand, speak, read, and write in English.
Able to provide voluntary written consent prior to the performance of any research related activity.
18 years of age or older at the time of consent.
Identified as a caregiver by a colorectal cancer patient.
Able to understand, speak, read, and write in English.
Able to provide voluntary written consent prior to the performance of any research related activity.

Exclusion

Lacks capacity to consent/diminished capacity to consent.

What this trial measures

  • Feasibility3 months

    Feasibility will be measured through rates of 1) initial engagement (i.e., percent of patients and caregivers who meet with a CLC representative), 2) continued engagement (i.e., percentage of patients and caregivers who respond to questionnaires at months 3), and 3) intervention completion (i.e., percentage of patients and caregivers who receive a legal service). The mean of the 3 metrics will be used to determine feasibility. The intervention will be deemed as feasible if ≥50% is met on each of the 3 feasibility metrics.